| ||
| Ambit Biosciences Begins Two Phase I Clinical Trials Trading Markets (press release) Excessive HER signaling has been associated with the development of a wide variety of types of solid tumors, including those found in lung, breast, ... See all stories on this topic » |
| ||
| White House To Encourage End-Of-Life Planning; Expect RWNJ's To ... By Alan The new rule says Medicare will cover "voluntary advance care planning," to discuss end-of-life treatment, as part of the annual visit. Under the rule, doctors can provide information to patients on how to prepare an "advance directive," stating ... He did not want anymore meds, but they kept him comfortable with Morphine, to manage his pain due to lung cancer. This is not a death panel it is to make the dying more comfortable. Posted by Rock December 26th, 2010 at 16:39 ... Alan Colmes' Liberaland - http://www.alan.com/ |
| ||
| Reportlinker Adds Gene Therapy - technologies, markets and companies Gene Therapy for ovarian cancer 259. Gene therapy for malignant melanoma 260. Gene therapy of lung cancer 262. Intravenous nanoparticle formulation for ... lungcancer.einnews.com/.../269397-reportlinker-adds-gene-th... | ||
| Lung Cancer Clinic - Cedars-Sinai The Lung Cancer Clinic offers a multidisciplinary approach to the treatment of lung cancer, including minimally invasive surgical options, access to cancer ... external2.csmc.edu/Patients/.../The-Lung-Cancer-Clinic/ | ||
| Targeted therapies usher in new era in cancer treatment | HemOncToday ... for melanoma, lung cancer and Hodgkin's disease The discovery of. ... The high response rate is clearly a major step forward in the treatment of this ... www.hemonctoday.com/article.aspx?rid=78699 |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment